Skip to main content

Table 2 Predictors of mortality among TB patients treated at DRH from January 2006 – December 2010

From: Mortality among tuberculosis patients under DOTS programme: a historical cohort study

Variables

Status

Adjusted hazard ratio (95 % CI)

p-value

Censored

Died

Gender

 Male

727

54

1

 

 Female

416

63

2.360 (1.518, 3.671)a

0.000

Age group

  < 20

129

34

1

 

 20–29

366

32

1.317 (0.629, 2.755)

0.465

 30–39

401

21

0.335 (0.156, 0.722)a

0.005

 40–49

120

17

1.029 (0.442, 2.394)

0.948

  > 49

127

13

1.687 (0.649, 4.385)

0.283

Residence

 Urban

1114

92

1

 

 Rural

29

25

4.230 (2.508, 7.136)a

0.000

Baseline weight

  < 20

54

20

1

 

 20–29

19

0

0.000 (0.000, 0.000)

0.957

 30–39

99

9

1.103 (0.420, 2.894)

0.843

 40–49

291

40

0.811 (0.332, 1.980)

0.646

  > 49

680

48

0.389 (0.178, 0.851)a

0.018

HIV status

 Positive

516

113

1

 

 Negative

627

4

0.010 (0.003, 0.027)a

0.000

CPT initiated

 No

688

79

1

 

 Yes

455

38

0.234 (0.145, 0.377)a

0.000

ART initiated

 No

891

88

1

 

 Yes

252

29

0.694 (0.414, 1.163)

0.166

Type of TB

 Smear positive

192

15

1

 

 Smear negative

472

30

0.417 (0.207, 0.837)a

0.014

 EPTB

479

72

1.149 (0.595, 2.222)

0.679

Treatment category

 New

944

109

1

 

 Retreatment

199

8

0.438 (0.191, 1.005)

0.051

  1. CPT Cotrimoxazole preventive therapy, ART-Antiretroviral therapy, TB Tuberculosis, EPTB Extrapulmonary TB
  2. aSignificant at α = 0.05